155
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Chronic Insomnia Is Associated with Higher Circulating Interleukin-8 in Patients with Atherosclerotic Cerebral Small Vessel Disease

, , , , &
Pages 93-99 | Published online: 11 Feb 2020

References

  • Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. doi:10.1016/S1474-4422(10)70104-6
  • Cuadrado-Godia E, Dwivedi P, Sharma S, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. J Stroke. 2018;20(3):302–320. doi:10.5853/jos.2017.02922
  • Fu Y, Yan Y. Emerging role of immunity in cerebral small vessel disease. Front Immunol. 2018;9:67. doi:10.3389/fimmu.2018.00067
  • Chen S, Yang Q, Chen G, Zhang JH. An update on inflammation in the acute phase of intracerebral hemorrhage. Transl Stroke Res. 2015;6(1):4–8. doi:10.1007/s12975-014-0384-4
  • Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34(1):43–62. doi:10.1007/s00281-011-0290-8
  • Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66:143–172. doi:10.1146/annurev-psych-010213-115205
  • Vgontzas AN, Zoumakis M, Papanicolaou DA, et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism. 2002;51(7):887–892. doi:10.1053/meta.2002.33357
  • Burgos I, Richter L, Klein T, et al. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun. 2006;20(3):246–253. doi:10.1016/j.bbi.2005.06.007
  • Savard J, Laroche L, Simard S, Ivers H, Morin CM. Chronic insomnia and immune functioning. Psychosom Med. 2003;65(2):211–221. doi:10.1097/01.psy.0000033126.22740.f3
  • Wang J, Chen X, Liao J, et al. The influence of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease. Neuropsychiatr Dis Treat. 2019;15:1009–1014. doi:10.2147/NDT.S193869
  • Roth T, Coulouvrat C, Hajak G, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International statistical classification of diseases and related health problems, tenth revision; and research diagnostic criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry. 2011;69(6):592–600. doi:10.1016/j.biopsych.2010.10.023
  • First MB, Spitzer RL, Gibbon M, Williams JB. The structured clinical interview for DSM-III-R personality disorders (SCID-II). Part I: description. J Pers Disord. 1995;9(2):83–91. doi:10.1521/pedi.1995.9.2.83
  • Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. doi:10.1016/S1474-4422(13)70124-8
  • Fazekas F, Chawluk JB, Alavi A, HI H, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–356. doi:10.2214/ajr.149.2.351
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.5th Ed. Washington, DC: American Psychiatric Association; 2013:362–363.
  • Rosenberg RS, Van Hout S. The American Academy of Sleep Medicine inter-scorer reliability program: sleep stage scoring. J Clin Sleep Med. 2013;9(1):81–87. doi:10.5664/jcsm.2350
  • Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–1234. doi:10.1212/WNL.0000000000000837
  • Liu X, Tang M, Hu L, et al. Reliability and validity of the Pittsburgh sleep quality index. Chin J Psychiatry. 1996;29(2):103–107.
  • Zhang MY. Handbook of Rating Scales in Psychiatry. Changsha: Hunan Science Publishing House; 2003:147–153.
  • Plante GE. Sleep and vascular disorders. Metabolism. 2006;55(10 Suppl 2):S45–S49. doi:10.1016/j.metabol.2006.07.013
  • Kim H, Yun CH, Thomas RJ, et al. Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population. Sleep. 2013;36(5):709B–715B. doi:10.5665/sleep.2632
  • Song TJ, Park JH, Choi KH, et al. Moderate-to-severe obstructive sleep apnea is associated with cerebral small vessel disease. Sleep Med. 2017;30:36–42. doi:10.1016/j.sleep.2016.03.006
  • Ferri R, Cosentino FI, Moussouttas M, et al. Silent cerebral small vessel disease in restless legs syndrome. Sleep. 2016;39(7):1371–1377. doi:10.5665/sleep.5966
  • Del Brutto OH, Mera RM, Zambrano M, Lama J, Del Brutto VJ, Castillo PR. Poor sleep quality and silent markers of cerebral small vessel disease: a population-based study in community-dwelling older adults (The Atahualpa project). Sleep Med. 2015;16(3):428–431. doi:10.1016/j.sleep.2014
  • Taylor KS, Murai H, Millar PJ, et al. Arousal from sleep and sympathetic excitation during wakefulness. Hypertension. 2016;68(6):1467–1474. doi:10.1161/hypertensionaha.116.08212
  • Bathgate CJ, Edinger JD, Wyatt JK, Krystal AD. Objective but not subjective short sleep duration associated with increased risk for hypertension in individuals with insomnia. Sleep. 2016;39(5):1037–1045. doi:10.5665/sleep.5748
  • Aggarwal B, Makarem N, Shah R, et al. Effects of inadequate sleep on blood pressure and endothelial inflammation in women: findings from the american heart association go red for women strategically focused research network. J Am Heart Assoc. 2018;7(12):e008590. doi:10.1161/JAHA.118.008590
  • Hall MH, Mulukutla S, Kline CE, et al. Objective sleep duration is prospectively associated with endothelial health. Sleep. 2017;40:1. doi:10.1093/sleep/zsw003
  • Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch. 2012;463(1):121–137. doi:10.1007/s00424-011-1044-0
  • Russo RC, Garcia CC, Teixeira MM, Amaral FA. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(5):593–619. doi:10.1586/1744666X.2014.894886
  • DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem. 1993;268(34):25568–25576.
  • Remick DG. Interleukin-8. Crit Care Med. 2005;33(12 Suppl):S466–S467. doi:10.1097/01.ccm.0000186783.34908.18
  • Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med. 2013;9(10):1003–1012. doi:10.5664/jcsm.3070
  • Aho V, Ollila HM, Rantanen V, et al. Partial sleep restriction activates immune response-related gene expression pathways: experimental and epidemiological studies in humans. PLoS One. 2013;8(10):e77184. doi:10.1371/journal.pone.0077184
  • Irwin MR, Wang M, Ribeiro D, et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008;64(6):538–540. doi:10.1016/j.biopsych.2008.05.004
  • Doyle SL, O’Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol. 2006;72(9):1102–1113. doi:10.1016/j.bcp.2006.07.010
  • Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637–650. doi:10.1016/j.immuni.2011.05.006
  • Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol. 2003;284(4):L566–L577. doi:10.1152/ajplung.00233.2002